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Murine hemopoietic stem cells are able to grow and differentiate in the spleen 
of lethally irradiated  syngeneic recipients.  The growth of bone marrow  grafts, 
however, is often suppressed in allogeneic irradiated  recipients, despite the fact 
that  such  animals  are  immunologically  deficient  and  do  not  mount  allograft 
responses to other tissues.  Moreover, hemopoietic grafts are often resisted also 
by irradiated F1 hybrid recipients, whereas even nonirradiated  F1 hybrids accept 
parental skin grafts (1-3). This phenomenon of allogeneic and hybrid resistance 
to hemopoietic grafts is regulated  by a  complex mechanism  that  is yet poorly 
understood (4).  Thus,  H-2  b parental bone marrow cells fail to grow in different 
(H-2  b x  non-H-2 b) crosses. Surprisingly,  these FI hybrids have been shown not 
to resist grafts from non-H-2 parents such as C3H or BALB/c (5-8). Moreover, 
resistance to H-2  b parental grafts has been noted only when such F~ hybrids were 
heterozygous at the H-2D region (9). 
Involvement  of the  H-2  gene  complex  in  a  phenomenon  with  apparently 
recessive inheritance  represents  a  difficult genetic  puzzle  (10).  Cudkowicz  (9) 
suggested  that  special  recessive,  tissue-specific  hemopoietic  histocompatibility 
(Hh) 1 genes, rather  than  classic histocompatibility genes, determine  the fate of 
hemopoietic grafts. He further assumed that H-2  b homozygotes carry the H-2D- 
linked Hh-I  a allele, that H-2  k and H-2  d mice carry the Hh-I  ° allele, and that the 
Hh-Ia/Hh-I ° heterozygotes do not express the  Hh-I  a allele.  This arrangement 
creates a peculiar situation where the H-2  b parent possesses a certain transplan- 
tation antigen that its F l hybrids lack (9). This hypothesis implies that hemopoietic 
grafts from any donors carrying the H-2D  b allele will be resisted as strongly as 
H-2  b parental  grafts,  whereas  grafts  from  H-2D  k- and  H-2Dd-carrying  donors 
will not be resisted by (H-2  b X H-2k)FI and (H-2  b ×  H-2d)F1  recipients,  respec- 
tively. 
Testing this prediction,  we found evidence that  the  K and  I  regions of H-2 
are involved in hemopoietic resistance in strain combinations in which involve- 
ment of the D region had already been demonstrated by others.  Moreover, we 
show that  in some of these strain  combinations,  unique hybrid Ia products are 
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responsible for hybrid resistance. The involvement of transcomplementation in 
hybrid resistance may suggest that the preferential association of major histocom- 
patibility complex (MHC)-encoded molecules is responsible for the absence of 
parental-specific determinants in F~ hybrids. 
Materials and Methods 
Mice.  C57BL/6  (B6),  C57BL/10  (B10),  BALB/c,  C3H/eb  (C3H),  (B6  x  C3H)F~, 
(B6 x  BALB/c)FI, (B10.HTG x  B6)Fb and (B10.HTG x  BALB/c)F~, and the recombi- 
nant  strains listed in  Table  I  were  obtained from  the  Animal Breeding Center of the 
Weizmann Institute of Science. 
Cell Preparation.  Bone marrow cells were obtained from 2-3-mo-old mice by flushing 
the  tibia and  femur  into  phosphate-buffered saline (PBS).  Cells were  centrifuged,  the 
pellet was resuspended in NH4C! buffer to lyse erythrocytes, washed twice, resuspended 
in PBS, and counted. 
Hemopoietic Stem  Cell Assay.  Colony-forming units/spleen  (CFU-S) were determined 
using the method of Till and McCuiloch (11). Briefly, the recipient mice were total-body 
irradiated (850  rad)  from  a  cobalt-60  source  and  injected intravenously with  varying 
numbers  (104-107)  of bone  marrow  cells. 8  d  later, the animals were  killed and  their 
spleens removed and  fixed in  Bouin's  solution.  After 2  h  of fixation, macroscopically 
visible spleen colonies were counted. 
The  number  of bone  marrow  cells needed  to  overcome hemopoietic resistance was 
determined in most donor-recipient combinations. Groups of 8-12  mice were  injected 
with  a  given  marrow  cell  dose,  and  arithmetic  means  and  standard  deviations were 
calculated from  individual spleen  counts.  Negative controls were  irradiated mice  that 
received no marrow cells. In all cases, the background spleen colony formation was no 
more than  0.2.  For positive controls,  bone  marrow  cells were  injected into irradiated 
syngeneic recipients. 
Results 
In preliminary studies we measured the strength of hybrid resistance in two 
parental-F1  combinations  by  determining  the  number  of bone  marrow  cells 
needed to overcome it, rather than registering the presence or absence of the 
phenomenon after injecting a single high dose of bone marrow cells (0.5 x  106 
to  106), as had been done by others (3). (B6 X C3H)F1 and (B6 X BALB/c)F1 
irradiated recipients were injected with various numbers of syngeneic hybrid and 
parental  marrow  cells  (Fig.  1).  As  a  control,  syngeneic  transplantation  was 
TABLE  I 
Genetic Composition of Strains Used 
B10.A (2R)  h2  k  k  k  k  k  k  d  b 
BI0.A (4R)  h4  k  k  k  k  b  b  b  b 
B10.HTG  g  d  d  d  d  d  d  d  b 
D2.GD  g2  d  d  d  d/b  b  b  b  b 
B10.A (5R)  i5  b  b  b  b  k  k  d  d 
A.AL  al  k  k  k  k  k  k  k  d 
A.TL  tl  s  k  k  k  k  k  k  d 
A.TFR-5  ap5  f  f  f  f  f  k  k  d 
C3H.OH  o2  d  d  d  d  d  d  d  k 
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FIGURE  l.  Variability of hybrid resistance.  CFU-S formation by irradiated BALB/c, B6, and 
C3H (A), (B6 × C3H)FI (B), and (B6 ×  BALB/c)F1  (C) recipients injected with graded doses 
of bone marrow cells from BALB/c (O) B6 (I--I), C3H (A), (B6  ×  C3H)FI (A), and (B6  × 
BALB/c)FI (O) donors. 
performed (Fig.  1 A), yielding similar results with all the strains used throughout 
this study (see Figs. 2-5). 
Experiments with F~ recipients gave somewhat unexpected results. Namely, a 
remarkable  difference was observed in  the strength  of resistance  of the above 
two F~ recipients to the parental grafts. Whereas 4 x  10  6 B6 bone marrow cells 
were needed to overcome hybrid resistance  to (B6  x  C3H)F~  hosts (Fig.  1 B), 
even 10  7 of the same marrow cells failed to grow in (B6 x  BALB/c)F1 hosts (Fig. 
1 C). Moreover, significant resistance of (B6 X BALB/c)F~ hybrids to 2 x  10  4 to 
10 5 BALB/c parental  marrow  cells was observed (Fig.  1 C),  whereas the  same 
number of C3H parental  cells grew unresisted  in  (B6  x  C3H)F1  hybrids (Fig. 
18). 
As seen in  Fig.  1 C, the growth of 0.5  ×  106 BALB/c parental  marrow  cells 
was not resisted by (B6 ×  BALB/c)F~ recipients.  This agrees with the findings 
of others (5-8) who used the same or higher cell doses. It appears, however, that 
this amount of cells grew unresisted because they were able to overcome hybrid 
resistance  to BALB/c parental  grafts,  which would have been revealed by the 
sensitive assay we used. It permits the detection of spleen colony formation in a 
much lower dose range (104-105). 
We repeated these experiments four times with virtually similar results. Hybrid 
resistance  was observable against both parental  strains,  although  to a  different 
degree, suggesting that  the strength of resistance to H-2  b parental  grafts by F~ 
hybrids depends on the genetic constitution  of the input  strains.  Hence,  these 
data raise the question whether H-2D-linked loci are the only factor determining 
this variable phenomenology. 
Are Loci of the H-2D Region Solely Responsible  for Hybrid Resistance?  To check 
whether H-2D-linked loci are the main and only factor determining  the fate of 
parental hemopoietic grafts, we measured the strength of resistance of the same DRIZLIKH  ET  AL.  1073 
F~ recipients used above toward marrow grafts from a set of H-2 recombinants 
and F1 hybrids carrying the H-2D  b, H-2D  d, and H-2D  k alleles, respectively. Thus, 
we were able to assess  the role of the left part of the H-2 complex in hybrid 
resistance. 
Irradiated (B6 x  BALB/c)F1 and (B6 x  C3H)F1 recipients were injected with 
graded doses of bone marrow cells from a series of H-2 recombinant strains all 
of which carry the H-2D  b allele (Fig. 2). It can be seen in Fig. 2B that up to 10 7 
B10.A(4R) or B10.A(2R) marrow cells were resisted by the (B6 x  BALB/c)FI 
recipients, whereas in (B6 x  C3H)F1 recipients (Fig. 2C), the smaller dose of 10  6 
cells from these strains gave values similar to the syngeneic controls (Fig.  2A). 
The opposite picture was observed with B 10.HTG and D2.GD grafts. They were 
strongly resisted only by (B6  x  C3H)F1  recipients (Fig.  2C) and much better 
tolerated by (B6 x  BALB/c)Fl recipients (Fig. 2B). 
The  data  show  that  all  four  H-2D  b grafts  were  resisted,  but  to  different 
degrees, supporting the conclusion of others (5, 6) that loci within or close to 
the H-2D region are responsible for hybrid resistance to H-2  b parental grafts. It 
is to be noted that differences in the strength of resistance cannot be attributed 
to the H-2D  b allele because all four donors shared it. 
The fact that B10.A(2R) and B10.HTG grafts, which are congenic and differ 
only at  H-2K  and  H-2I,  behave differently, whereas  B10.HTG  and  D2.GD, 
which share H-2K and H-2A but differ in their background, behave similarly, 
rules out the possibility that genes outside the H-2 have a  significant effect in 
these experiments. Hence, the data suggest the involvement of the left part of 
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FIGURE 2.  The H-2D  b allele and hybrid resistance. CFU-S formation by irradiated syngeneic 
(A), (B6 x  BALB/c)FI (B), and (B6 x  C3H)F, (C) recipients injected with graded doses of bone 
marrow cells from the H-2D  b allele-carrying donors:  D2.GD (F1), B10.HTG (O),  BI0.A(2R) 
(A), and B10.A(4R) (~7). 1074  GENETICS OF HEMOPOIETIC RESISTANCE 
the  H-2  complex  in  hybrid  resistance.  Moreover,  the  recipients  showed  the 
strongest resistance, similar in strength to that against B6 parental grafts, toward 
the recombinant donor, which was fully mismatched relative to the input strains, 
e.g., B 10.A(2R) and B 10.A(4R) with BALB/c in the (B6 × BALB/c)F1 recipients 
and B10.HTG and D2.GD with C3H in the (B6 × C3H)FI recipients. Conversely, 
when the donor shared with the input strain the H-2K and H-2I regions, e.g., in 
B10.A(2R) and  B10.(4R) vs.  C3H, or B10.HTG and  D2.GD vs.  BALB/c, the 
resistance was considerably weaker. 
The data suggest that the strength of resistance of F] hybrids to hemopoietic 
grafts from donors that share the H-2D allele with the H-2  b parent is considerably 
influenced  by  the  H-2K  and/or  H-2I  regions.  They  also  imply  that  strong 
resistance to B6 parental  grafts might be attributed to disparities at both H-2D 
and  H-2K  or  H-2I  regions  between  B6  parents  and  BALB/c or  C3H  input 
strains. 
To further  elucidate the role of the H-2D region  in hemopoietic resistance, 
we  explored  the  above described  observation  of weak  resistance  to  BALB/c 
parental grafts (Fig.  1 C). (B6 × BALB/c)F] recipients were injected with graded 
doses of bone marrow cells from four H-2 recombinant strains, all of which carry 
the H-2D  d allele, and with BALB/c parental  marrow cells (Fig.  3B). It can be 
seen that A.TFR-5 and BALB/c grafts were resisted, whereas A.AL, A.TL, and 
B10.A(5R) cells grew unresisted, as in syngeneic recipients (Fig. 3A). These data 
show that, unlike the H-2D  b allele, expression of the H-2D  d allele by recombinant 
donors  does not  necessarily  lead  to  rejection  of hemopoietic  grafts  by (B6  x 
BALB/c)F] recipients.  The different fate of H-2D  d grafts in these experiments 
also cannot be attributed to differences in the genetic background, since grafts 
from congenic A.AL and A.TFR-5 donors were accepted and rejected, respec- 
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FIGURE 3.  The H-2D  d  and H-2D  k  alleles and hybrid resistance. CFU-S  formation by irradi- 
ated syngeneic (A), (B6 X BALB/c)F] (B), and (B6 x  CBH)F] (C) recipients injected with 
graded doses of bone marrow cells from B10.A(5R) (O), A.TL (I-I), A.AL (A), A.TFR-5 (A), 
BALB/c (Q), and C3H.OH (D) donors. DRIZLIKH  ET  AL.  1075 
tively,  whereas  grafts  from  donors  with  different  background,  namely  from 
B10.A and A.AL or A.TL, were accepted. The only factor in these experiments 
that correlated with the acceptance of H-D  d grafts by (B6 X BALB/c)F1 recipients 
is combinatorial specificity Ia.22. The latter was shown to be formed by the I-E  k 
molecule,  born  by  both  A.AL  and  A.TL,  and  also  by  ciscomplementation 
(Eak:E#  b) in B10.A(5R) or by transcomplementation (E,d:Et~  b) in (H-2 b X  H-2d)F1 
hybrids. Neither BALB/c nor A.TER-5 forms this determinant (12-15).  Hence, 
the data shown in Fig. 3B may tentatively suggest the involvement of the class 
II MHC products in hemopoietic resistance. 
In the last experiment shown (Fig. 3B), congenic C3H.OH bone marrow cells 
were injected into (B6 X C3H)F~ irradiated recipients. Unlike the C3H parental 
cells, these cells were  resisted by the  F1  host.  Since C3H  and C3H.OH  share 
genetic background and H-2D, the resistance observed can be attributed to the 
H-2K and H-2I regions of the complex. 
Allogeneic Resistance  in  the  H-2D  Compatible Donor Recipient Combinations. 
Previous experiments in which F~ recipients were grafted with marrow cells from 
H-2 recombinants represent a rather complicated variant of allotransplantation. 
Studies  of a  simple  homozygous strain  combination,  where  neither  recessive 
inheritance nor transcomplementation took place, suggest that allogeneic resist- 
ance to hemopoietic grafts is caused by H-2D disparities only. In these experi- 
ments, in which a relatively high dose of bone marrow cells was used (0.5 ×  106 
to  106 cells),  no resistance  was  observed in  H-2D  compatible,  H-2K,  or  H-2I 
incompatible donor-recipient combinations (16). 
In the present work,  we reinvestigated allogeneic resistance  and used lower 
bone marrow cell doses (5 x  104 to  105). Fig. 4 demonstrates that in this more 
sensitive experimental arrangement, significant resistance was observed in three 
congenic, recombinant, H-2Db-identical strain combinations, suggesting the in- 
volvement of the H-2K and H-2I regions not only in hybrid but also in allogeneic 
resistance. 
Unique Hybrid Class II Antigens and Hemopoietic Resistance.  The results in Fig. 
3  suggested  that  unique  Ia  products  in  F1  hybrids  and  their  absence  in  the 
parental donor may facilitate hybrid resistance. To get a better insight into the 
problem,  we  prepared  F~  crosses  between  B10.HTG  and  BALB/c  and  used 
them as irradiated recipients of graded doses of BALB/c bone marrow cells. As 
a control, the same BALB/c cells were injected into (B6 X BALB/c)F~ recipients. 
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FIGURE 4.  The H-2D  b allele and allogeneic resistance. Growth of B10 bone marrow (BM) 
cells in irradiated syngeneic and congenic recombinant, H-2D compatible recipients. 1076  GENETICS  OF  HEMOPOIETIC  RESISTANCE 
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FIGURE 5.  The unique hybrid Ia molecules and hybrid resistance. CFU-S formation by (A) 
irradiated syngeneic recipients; (B) irradiated (B10.HTG x  BALB/c)FI (O----O) and (B6  x 
BALB/c)FI (O--0) recipients injected with BALB/c parental bone marrow cells; (C) irradiated 
(B6 x C3H)FI and (D) (B6 × BALB/c)FI recipients injected with graded doses of bone marrow 
cells from (B10.HTG x  B6)FI (O), B10.HTG (A), and B6 (I-7)  donor cells. 
Fig. 5B shows that unlike (B6 x  BALB/c)Fb (B10.HTG x  BALB/c)F~ recipients 
tolerated the BALB/c parental grafts. We attributed this absence of resistance 
to the fact that in  (B10.HTG  X BALB/c)F],  unlike in (B6  x  BALB/c)Fh  no 
unique F~ hybrid determinants are formed, because the parents carry identical 
I-A and I-E alleles. 
Next, the possible involvement of unique Ia products was approached using a 
strain combination where the H-2D  b allele could contribute to the strength of 
hemopoietic resistance.  H-2D  b homozygous (B10.HTG  X  B6)F1 hybrid bone 
marrow cells were injected into irradiated (B6 x  CBH)F1  or (B6 X BALB/c)F1 
recipients. As the control, parental B 10.HTG and B6 marrow cells were injected 
into  similar recipients.  Syngeneic control groups  also  were included in  these 
experiments (Fig. 5A). 
Fig. 5C shows that (B10.HTG ×  B6)F, donor cells grew in the (B6 ×  C3H)F~ 
recipients  somewhat  better  than  B10.HTG  or  B6  parental  donor  cells.  In 
contrast, in the (B6 ×  BALB/c)F] recipients, the growth of (B10.HTG × B6)F~, 
B 10.HTG, and B6 grafts differed significantly. As shown in Fig. 5 D (B 10.HTG 
×  B6)F]  grafts were accepted by the (B6 ×  BALB/c)FI recipients at an almost 
10-fold  lesser  cell  dose  than  B10.HTG  grafts.  An  even  much  higher  dose 
difference was observed between (B10.HTG ×  B6)F] and B6 grafts. 
Since the combinations are syngeneic for non-H-2 genes, this different behav- DRIZLIKH  ET  AL.  1077 
ior of parental B10.HTG and B6 vs. (B10.HTG ×  B6)F1 hybrid donors can be 
explained only by complementation in the (B 10.HTG x  B6)FI donor cells, which 
had to occur between H-2  d and H-2  b alleles and may have been due to transcom- 
plementation  of the  respective  parental  Ia  products  (A~:A0  and  E,:Ea)  (17). 
Hence, a different behavior of the (B10.HTG  x  B6)F1 donor grafts in the (B6 
×  C3H)F~  vs.  (B6  ×  BALB/c)F~  recipient may be attributed  to  the fact that 
(B10.HTG ×  B6)F1 donors and (B6 ×  C3H)F1 recipients form different hybrid 
Ia products (except for the Ia.22 specificity), whereas (B 10.HTG × B6)F1 donors 
and (B6 x  BALB/c)F1 recipients form the identical unique hybrid Ia products. 
Taken together, the experiment shown in Figs. 3 and 5 suggest the involvement 
of unique hybrid class II antigens in hemopoietic resistance. 
Discussion 
Resistance to nonsyngeneic hemopoietic grafts violates fundamental laws of 
transplantation  mainly because of radiation  resistance and apparent  recessive 
inheritance. This led Cudkowicz and his colleagues to the conclusion that not 
the classic but special H-2D-linked recessive hemopoietic histocompatibility genes 
control hemopoietic resistance. 
Here  we  investigated the quantitative  aspects  of hemopoietic resistance  to 
grafts carrying the H-2D  b, H-2D  d, and H-2D  k alleles, respectively. The data we 
obtained cannot be explained by the assumption that an H-2D-associated reces- 
sive allele is the main and only factor of hemopoietic resistance in these experi- 
ments. Our data suggest that genes outside the H-2D, possibly in the left part of 
the H-2 complex, are also responsible. This assumption is based on the following 
findings: (a) Grafts carrying the H-2D  b allele were resisted by congeneic, H-2D- 
identical,  H-2K-  and  H-2I-incompatible  recipients  (Fig.  4).  The  strength  of 
resistance of (B6 x  BALB/c)Fl and (B6 × C3H)F1 recipients was weak, when H- 
2D  b donors shared H-2K and H-2I alleles with the input strain of the F~ recipient 
(Fig. 2), or when the donors and the recipients formed identical unique hybrid 
class  II antigens (Fig.  5D).  (b) The fate of grafts from H-D  d donors seems to 
depend on  the incompatibility of a  combinatorial determinant Ia.22.  If both 
donor and recipient expressed such a hybrid determinant (either in the cis or in 
the transposition),  or if neither could form such determinants, grafts were not 
resisted (Figs.  3B and 5B). (c) The H-2D  k allele is not the only factor that confers 
to  C3H  parental  bone  marrow cells the ability to  grow  unresisted  in  (B6  x 
C3H)F1  recipients, since grafts from congeneic C3H.OH  donors, carrying the 
same H-2D  k allele and differing at the left part of the H-2 complex, were resisted 
(Fig. 3C). 
Taken together, these data suggest the involvement of the H-2K and H-2I 
regions in  hemopoietic resistance and raise the possibility that the A,, A s,  E~, 
and Ea genes rather than some other H-2I-linked loci are involved. This conclu- 
sion agrees with  the recent study of the molecular map of the H-2  complex, 
which revealed that the I region has no room for any yet unknown genes (18). 
Our observations agree with some findings of others. Involvement of the H- 
2K and H-2I regions in hybrid resistance to tumor cells, a phenomenon related 
to  hemopoietic resistance,  was recently reported.  It  has been shown that  the 
strength of resistance is affected by mutations of the H-2K  b and H-2A  b genes 1078  GENETICS  OF  HEMOPOIETIC  RESISTANCE 
(19).  Bennett (20) found that in some situations,  F1  hybrid recipients accepted 
marrow allografts from heterozygous but not from homozygous donors. Thus, 
(B10  ×  C3H)FI  recipients  rejected  both  B10  parental  and  DBA/2  or  WB 
allogeneic marrow grafts. The F1 hybrids, however, accepted (B10 × DBA/2)F1 
but  not  (WB  x  DBA/2)F1  marrow  grafts.  This  phenomenon resembles our 
present observation with (B10.HTG x  B6)F,  donor cells (Fig.  5D) and may be 
generally attributed to the fact that different heterozygotes can share hybrid Ia 
molecules, which neither of the homozygous parents express. On the other hand, 
at least some of the H-2D-linked loci that have been shown to control hemopoietic 
resistance appeared to be classic  MHC genes, since mutations of the H-2D  d and 
H-2L  d genes are able to alter both allogeneic (21) and hybrid (8, 22) resistance. 
Accordingly, FI  hybrids were shown to generate in vitro antiparental cytotoxic 
T  lymphocytes directed toward parental class I MHC antigens (7, 23). 
Taken together, these data suggest that MHC genes, rather than special Hh 
genes,  determine  the  fate  of hemopoietic  grafts.  This  conclusion,  however, 
creates a  paradox:  According to  the  laws  of transplantation, parents  do  not 
express H-2 antigens, which Fz hybrids lack, but experimental data suggest that 
they do. 
The phenomenon of hemopoietic resistance raises two yet unanswered ques- 
tions:  What  is  the  nature  of the  determinants that  homozygous parents  are 
supposed to possess but their Fa  hybrids lack, and what is the mechanism that 
enables lethally irradiated animals to resist nonsyngeneic hemopoietic grafts? 
Here we propose a  hypothesis to answer these questions.  We postulate that 
there exist parental determinants that are not formed in some  FI hybrids due to 
preferential association of either Ia a  chains with allogeneic/3 chains or class  I 
antigens with ailogeneic or hybrid class II restriction elements. 
Preferential association of E~ chains with either syngeneic (24) or allogeneic 
(25)  Ea chains  in  some  F~  hybrids  has  been  recently described.  The  authors 
suggested that preferential association of Ia chains might be a general trait and 
might include formation of A~:Aa complexes (25).  Indeed, a  strain  A  anti-B6 
alloreactive T  cell clone has been described, which could have been stimulated 
by B6  but  not  (B6  x  A)Fa  cells.  This  implies the presence of a  unique  H-2  b 
parental  MLR-stimulating determinant that  is  absent  on  heterozygous (B6  × 
A)FI cells (26). It is possible that this determinant is the A,b:Ae  b complex, which 
is not formed in (B6  ×  A)F1 hybrids because of the preferential association of 
Aa  b  chain with allogeneic Aa  k chain.  Moreover, the absence of this particular 
determinant in (B6 × A)F, hybrids might possibly account for their resistance to 
B6 parental bone marrow grafts. 
There is no evidence suggesting preferential association of class I with class II 
products.  The existence of such complexes was postulated by  Matzinger and 
Bevan (27).  Later it was shown that Ia-positive splenic adherent cells are predom- 
inant stimulators of a  mixed lymphocyte response to  the non-H-2-1inked Mls 
products  or  to  products  of the  K  and  D  regions of H-2  (28).  Furthermore, 
monoclonal antiresponder Ia antibodies inhibited the proliferative response to 
class I (H-2K/D) MHC antigens (29) and both the proliferative and the cytotoxic 
response of B6 responders to H-2K  ~  mutant class I antigen (30). 
The question whether tolerance to these antigens is Ia restricted is still  open DRIZLIKH  ET  AL.  1079 
(31). In any case, the data indicate that class I MHC antigens can be recognized 
by proliferative and T  helper cells in association with syngeneic Ia molecules. 
Hence, these antigens seem to behave like conventional soluble antigens. The 
latter, however, were shown to be able to associate with both ciscomplementing 
and transcomplementing Ia proteins (32), and sometimes, being given a  choice 
of several restriction elements, preferentially associated with one of them (33). 
Therefore, it is conceivable that certain Fa heterozygotes do not form some of 
the parental-specific class I and II complexes and hence regard them as non-self. 
The proposed model makes it possible to understand why Fa hybrids are able 
to  react  in  one  or another way against  parental  tissues.  However, the exact 
cellular mechanism of hybrid resistance is still unknown. Natural killer cells were 
suggested to be responsible for hemopoietic graft rejection (34).  Recently (35), 
it has been shown that very few host T  lymphocytes, which survived irradiation, 
were  sufficient to  suppress  growth  of hemopoietic allografts.  An  alternative 
cellular mechanism has been proposed by Lengerova and colleagues (21,  36). 
They presented evidence that  hemopoietic allografts  fail to  grow due to  the 
inability of nonsyngeneic stroma to provide an appropriate differentiative signal 
to hemopoietic stem cells. We assume that whichever cells are responsible for 
hemopoietic resistance, they either recognize class I and II complexes expressed 
on  hemopoietic stem  cells as foreign or  do  not  recognize them as  self.  It  is 
conceivable that similar mechanisms also regulate bone marrow engraftment in 
humans. 
Summary 
Irradiated (H-2  b ×  H-2k)F1 and (H-2  b ×  H-2d)Fl recipients strongly resist the 
growth of H-2  b parental bone marrow cells and do not resist marrow grafts from 
non-H-2  b  parents  such  as  C3H  and  BALB/c.  This  phenomenon  of hybrid 
resistance has been shown to be under genetic control of the H-2D-linked loci 
and was interpreted by Cudkowicz (9)  as due to the existence of H-2D-linked 
recessive hemopoietic histocompatibility genes. 
To check whether the H-2D-linked loci are solely responsible for the fate of 
bone marrow allografts, we measured the strength of resistance of irradiated (B6 
×  C3H)F1 and (B6 ×  BALB/c)F1 recipients toward bone marrow grafts from a 
set of H-2 recombinant and F1  hybrid donors carrying either the H-2  b,  H-2  d, 
and H-2  k alleles. 
We found that growth of all  H-2  b grafts was resisted, although to different 
degrees. Resistance was minimal when donors shared with the input strain of a 
corresponding FI hybrid the H-2K and H-2I regions, or when both F1 donors 
and F1 recipients formed identical unique hybrid Ia molecules. In addition, H- 
2 b grafts were resisted by congenic, H-2D-identical, H-2K- and H-2I-incompatible 
recipients. 
The fate of grafts from H-2D  d donors seemed to depend on the incompatibility 
of the combinatorial determinant Ia.22.  If both donor and recipient expressed 
such a determinant (either in the cis or in the transposition), or if neither could 
form such a determinant, grafts were not resisted. 
The  H-2D  k allele is  not  the  main or only factor  that  confers on the C3H 
parental  bone  marrow  cells  the  ability  to  grow  unresisted  in  (B6  ×  C3H)F~ 1080  GENETICS  OF  HEMOPOIETIC  RESISTANCE 
recipients.  Grafts  from  congenic  C3H.OH  donors,  carrying  the  same  H-2D  k 
alleles and differing in the left part of the H-2 complex, were resisted by the F1 
recipients.  We conclude that  both class  I  (K and  D) and  class  II  (I-A and  I-E) 
major histocompatibility complex genes,  rather than  hypothetical hemopoietic 
histocompatibility genes control hemopoietic resistance. 
To reconcile codominant inheritance of classic H-2 antigens with the apparent 
recessive inheritance  of hybrid resistance,  we  assume  that  there exist parental 
determinants that are not formed in some FI hybrids due to preferential associ- 
ation of either Ia  a  chains  with allogeneic/3 chains or of class  I  antigens  with 
allogeneic or hybrid class II restriction elements. 
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